Monitor future filings for revenue contribution from the Indian pharmaceutical customer win and progress on the integrated enclosure manufacturing. Without disclosed financial terms, this is a qualitative update with no immediate revenue impact.
Price Chart
Executive Summary
TOMI Environmental Solutions announced growing adoption of its SteraMist iHP technology in India's pharmaceutical sector through partner STS Technocrat, including a signed customer win with a well-known pharmaceutical company and plans to manufacture a turnkey integrated enclosure. The press release contains no financial figures, no revenue or earnings data, and no binding contractual commitments — it is a routine commercial update.
Key Facts
- STS Technocrat (India) Pvt. Ltd. signed a well-known pharmaceutical company as a SteraMist customer in India
- STS Technocrat is working with TOMI to manufacture a turnkey, fully integrated SteraMist iHP enclosure
- India's pharmaceutical market grew from USD 68.38 billion (2025) to USD 75.89 billion (2026), projected to reach USD 174.67 billion by 2034 (CAGR 10.98%)
- No financial terms, revenue contribution, or binding contractual commitments were disclosed
Financial Impact
No financial figures disclosed — customer win and enclosure development are commercial milestones without stated revenue or deal value
Risk Factors
- No binding contractual commitments or revenue figures disclosed
- Reliance on a single partner for Indian market penetration
- Forward-looking statements subject to execution risk and competitive dynamics
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3372891 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 8-K | $1.44 | awaiting T+20 | — | $1.43 (−0.69%) |
Oct 15, 2026 11d ago | Press Release | $1.50 | awaiting T+20 | — | $1.43 (−4.67%) |
Oct 1, 2026 25d ago | Press Release | $1.36 | awaiting T+20 | — | $1.43 (+5.15%) |
Sep 21, 2026 5w ago | 8-K | $1.46 $1.47 | ▲ +0.68% | ▲ +1.24% | $1.43 (−2.05%) |
Sep 21, 2026 5w ago | Press Release | $1.46 $1.47 | ▲ +0.68% | ▲ +1.24% | $1.43 (−2.05%) |
Sep 18, 2026 5w ago | Press Release | $1.46 $1.47 | ▲ +0.68% | ▲ +0.48% | $1.43 (−2.05%) |
Sep 2, 2026 7w ago | 8-K | $1.66 $1.36 | ▼ −18.07% | ▼ −17.92% | $1.43 (−13.86%) |
Aug 14, 2026 10w ago | 8-K | $1.75 $1.58 | ▼ −9.71% | ▼ −7.72% | $1.43 (−18.29%) |
Aug 14, 2026 10w ago | Press Release | $1.75 $1.58 | ▼ −9.71% | ▼ −7.72% | $1.43 (−18.29%) |
Jul 29, 2026 12w ago | 8-K | $1.52 $1.73 | ▲ +13.82% | ▲ +8.80% | $1.43 (−5.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers